StockData
Inventiva S.A. logo

Inventiva S.A. (IVA) KPIs and segments

IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 1/30
$3.22−0.10 (-3.01%)

Close on Nov 17, 2026Market cap $622.22MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Inventiva's business

Inventiva's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
China(€M)
4.489.134.6112.1
France(€M)
0.070.120.130.190.37
Earlier reporting (last reported 2023)2

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-04-08.

See a number that looks wrong?